Reza Nejadnik is a senior scientist in the Global Pharmaceutical Development Biologics department at Sanofi. He is responsible for biologics formulation and associated developability and deviceability considerations. As a member of the drug product development teams, he is actively involved in innovation activities and investigation of the stability of various drug products.
Reza has a long track of collaborating with various partners in industry and academia for addressing the challenges concerning the formulation, characterization and delivery of biologics. Reza has authored several scientific articles and given numerous presentations on stability topics and has been an active member of professional associations working towards safe and efficient delivery of biopharmaceuticals to patients.